NDC codes

466581 NDC codes with hospital pricing data in the network.

• NDC 0338004941 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (65 hospitals, 304–1,204 samples)
• NDC 0338004948 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (67 hospitals, 304–1,204 samples)
• NDC 0409115901 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (48 hospitals, 304–1,204 samples)
• NDC 0409115902 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (45 hospitals, 304–1,204 samples)
• NDC 0409115909 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (21 hospitals, 304–1,204 samples)
• NDC 0409115918 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (31 hospitals, 304–1,204 samples)
• NDC 0409115919 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (26 hospitals, 304–1,204 samples)
• NDC 0409116001 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (40 hospitals, 304–1,204 samples)
• NDC 0409116018 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (22 hospitals, 304–1,204 samples)
• NDC 0409132305 — LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE (69 hospitals, 304–1,204 samples)
• NDC 0409132315 — LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE (45 hospitals, 304–1,204 samples)
• NDC 0409155919 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLUTION (27 hospitals, 304–1,204 samples)
• NDC 0409206605 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (43 hospitals, 304–1,204 samples)
• NDC 0409427602 — LIDOCAINE 10 MG/ML (1 %) INFUSION (ANESTHESIA ONLY) (SO) (41 hospitals, 304–1,204 samples)
• NDC 0409427617 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (40 hospitals, 304–1,204 samples)
• NDC 0409427717 — LIDOCAINE HCL 20 MG/ML (2 %) INJECTION SOLUTION (41 hospitals, 304–1,204 samples)
• NDC 0409427902 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (44 hospitals, 304–1,204 samples)
• NDC 0409471332 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (38 hospitals, 304–1,204 samples)
• NDC 0409471342 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (22 hospitals, 304–1,204 samples)
• NDC 0409471375 — LIDOCAINE 10 MG/ML (1 %) INJECTION (SO) (28 hospitals, 304–1,204 samples)
• NDC 0409488710 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (35 hospitals, 304–1,204 samples)
• NDC 0409488717 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (45 hospitals, 304–1,204 samples)
• NDC 0409488720 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (34 hospitals, 304–1,204 samples)
• NDC 0409488723 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (48 hospitals, 304–1,204 samples)
• NDC 0409488724 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (32 hospitals, 304–1,204 samples)
• NDC 0409488725 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (31 hospitals, 304–1,204 samples)
• NDC 0409488750 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (46 hospitals, 304–1,204 samples)
• NDC 0409488799 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (28 hospitals, 304–1,204 samples)
• NDC 0409490311 — LIDOCAINE (PF) 100 MG/5 ML (2 %) INTRAVENOUS SYRINGE (47 hospitals, 304–1,204 samples)
• NDC 0409792202 — DEXTROSE 5 % IV BOLUS (23 hospitals, 304–1,204 samples)
• NDC 0409792225 — DEXTROSE 5 % IV BOLUS (21 hospitals, 304–1,204 samples)
• NDC 0409792261 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION (24 hospitals, 304–1,204 samples)
• NDC 0409792313 — DEXTROSE 5 % IV BOLUS (22 hospitals, 304–1,204 samples)
• NDC 0409792323 — DEXTROSE 5 % IV BOLUS (21 hospitals, 304–1,204 samples)
• NDC 0409792336 — DEXTROSE 5 % IV BOLUS (22 hospitals, 304–1,204 samples)
• NDC 0409792337 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION (21 hospitals, 304–1,204 samples)
• NDC 0409798423 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (20 hospitals, 304–1,204 samples)
• NDC 0487610501 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (22 hospitals, 304–1,204 samples)
• NDC 0517300501 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (40 hospitals, 304–1,204 samples)
• NDC 0517300525 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (57 hospitals, 304–1,204 samples)
• NDC 0641602201 — FAMOTIDINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION (45 hospitals, 304–1,204 samples)
• NDC 0641602225 — FAMOTIDINE (PF) 20 MG/2 ML INTRAVENOUS SOLUTION (47 hospitals, 304–1,204 samples)
• NDC 0641614701 — WATER FOR INJECTION, STERILE INJECTION SOLUTION (SO) (27 hospitals, 304–1,204 samples)
• NDC 0904600861 — LORAZEPAM 1 MG TABLET (57 hospitals, 304–1,204 samples)
• NDC 0990798437 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (61 hospitals, 304–1,204 samples)
• NDC 5038377515 — LIDOCAINE 2 % MUCOSAL SOLUTION BRONCH (39 hospitals, 304–1,204 samples)
• NDC 5038377517 — LIDOCAINE 2 % MUCOSAL SOLUTION BRONCH (31 hospitals, 304–1,204 samples)
• NDC 5515016072 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (SO) (20 hospitals, 304–1,204 samples)
• NDC 5515016402 — LIDOCAINE (PF) 20 MG/ML (2 %) INJ SOLN (51 hospitals, 304–1,204 samples)
• NDC 5515016710 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (37 hospitals, 304–1,204 samples)